Two Dosing Regimens of Certolizumab Pegol in Patients With Active Rheumatoid Arthritis

OBJECTIVE: To investigate clinical efficacy and safety of 2 certolizumab pegol (CZP) maintenance dosing regimens plus methotrexate (MTX) in active rheumatoid arthritis (RA) patients achieving the American College of Rheumatology 20% improvement criteria (ACR20) after the CZP 200 mg every 2 weeks ope...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Arthritis Care Res (Hoboken)
Main Authors: Furst, D E, Shaikh, S A, Greenwald, M, Bennett, B, Davies, O, Luijtens, K, Staelens, F, Koetse, W, Bertin, P
Formato: Artigo
Idioma:Inglês
Publicado em: BlackWell Publishing Ltd 2015
Assuntos:
Rheumatoid Arthritis
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4329409/
https://ncbi.nlm.nih.gov/pubmed/25302624
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acr.22496
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados